SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-399418
Filing Date
2015-12-10
Accepted
2015-12-10 06:10:54
Documents
6
Period of Report
2015-12-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d13740d8k.htm 8-K 13837
2 EX-99.1 d13740dex991.htm EX-99.1 16735
3 EX-99.2 d13740dex992.htm EX-99.2 18597
4 EX-99.3 d13740dex993.htm EX-99.3 19991
5 GRAPHIC g13740new1.jpg GRAPHIC 745327
6 GRAPHIC g13740new2.jpg GRAPHIC 634281
  Complete submission text file 0001193125-15-399418.txt   1970845
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36274 | Film No.: 151279648
SIC: 2834 Pharmaceutical Preparations